PHEON THERAPEUTICS LTD

Active Sandwich

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHEON THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 8 Jul 2015 Active Sandwich, United Kingdom 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

FEMTOGENIX LTD 8 Jul 2015 — 3 Aug 2022
Accounts Submitted 30 Oct 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 30 Oct 2025 Next due 2 Nov 2026 4 months remaining
Net assets £36M £19M 2024 year on year
Total assets £42M £23M 2024 year on year
Total Liabilities £5M £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Innovation House Innovation Way Discovery Park Sandwich Kent CT13 9FF United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for PHEON THERAPEUTICS LTD (09677410), an active life sciences and medical technology company based in Sandwich, United Kingdom. Incorporated 8 Jul 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£37.68M

Increased by £20.91M (+125%)

Net Assets

£36.36M

Increased by £18.89M (+108%)

Total Liabilities

£5.36M

Increased by £3.74M (+232%)

Turnover

N/A

Employees

11

Increased by 2 (+22%)

Debt Ratio

13%

Increased by 5 (+63%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2022Series B, Series A
Investor 2Sept 2022Series B, Series A
Investor 5Sept 2022Series B, Series A

Share Capital

Share Capital

Share allotments and capital structure

66 Allotments 59,530,953 Shares £120.63m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Oct 20254,084,967£9.39m£2.299
15 Oct 20252,036,437£4.68m£2.299
15 Oct 20251,765,032£4.06m£2.299
15 Oct 2025221,405£509k£2.299
15 Oct 202562,091£143k£2.299

Officers

Officers

1 active 2 resigned
Status
Jeffery AlbersDirectorAmericanUnited States541 Jan 2023Active

Shareholders

Shareholders (54)

Tcg Crossover Fund Ii, L.p
10.7%
8,169,934
Atlas Venture Fund Xii, L.p
10.4%
7,909,320

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Oct 2025AccountsAnnual accounts made up to 31 Mar 2025
30 Oct 2025CapitalAllotment of shares (GBP 7,608.9809) on 15 Oct 2025
30 Oct 2025Confirmation StatementConfirmation statement made on 19 Oct 2025 with updates
11 Aug 2025OfficersAppointment of Mr Samuel Blackman as director on 30 Jun 2025
2 May 2025CapitalAllotment of shares (GBP 5,648.1976) on 12 Feb 2025
30 Oct 2025 Accounts

Annual accounts made up to 31 Mar 2025

30 Oct 2025 Capital

Allotment of shares (GBP 7,608.9809) on 15 Oct 2025

30 Oct 2025 Confirmation Statement

Confirmation statement made on 19 Oct 2025 with updates

11 Aug 2025 Officers

Appointment of Mr Samuel Blackman as director on 30 Jun 2025

2 May 2025 Capital

Allotment of shares (GBP 5,648.1976) on 12 Feb 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

7 months ago on 30 Oct 2025

Allotment of shares (GBP 7,608.9809) on 15 Oct 2025

7 months ago on 30 Oct 2025

Confirmation statement made on 19 Oct 2025 with updates

7 months ago on 30 Oct 2025

Appointment of Mr Samuel Blackman as director on 30 Jun 2025

10 months ago on 11 Aug 2025

Allotment of shares (GBP 5,648.1976) on 12 Feb 2025

1 years ago on 2 May 2025